Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

• Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
  FA Ragab, NMA Gawad, HH Georgey, MF Said
  2013

 

• Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
  AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
  2022

 

• Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
  FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
  2013

 

• Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
  RF George, MF Said, S Bua, CT Supuran
  2020

 

• Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
  MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
  2022

 

• Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
  HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
  2017

 

• New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
  RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
  2023

 

• Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
  IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
  2022

 

• Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
  MF Said, HH Georgey, ER Mohammed
  2021

 

• Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
  MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
  2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.